These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7345094)

  • 1. Formulation and evaluation of sustained release paracetamol tablets.
    Ahmed M; Enever RP
    J Clin Hosp Pharm; 1981 Mar; 6(1):27-38. PubMed ID: 7345094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relative bioavailability of paracetamol from tablets and suppositories as well as of paracetamol and codeine in a combination tablet].
    Klein G; Barkworth MF; Birkenfeld A; Dyde CJ; Rehm KD; Töberich H; Cierpka H
    Arzneimittelforschung; 1986 Mar; 36(3):496-9. PubMed ID: 3518729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.
    Yue Y; Liu DJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):87-94. PubMed ID: 28816033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging to Visualize Disintegration of Oral Formulations.
    Curley L; Hinton J; Marjoribanks C; Mirjalili A; Kennedy J; Svirskis D
    J Pharm Sci; 2017 Mar; 106(3):745-750. PubMed ID: 27964901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix properties of a new plant gum in controlled drug delivery.
    Kalu VD; Odeniyi MA; Jaiyeoba KT
    Arch Pharm Res; 2007 Jul; 30(7):884-9. PubMed ID: 17703742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of some excipients on the physical properties of a paracetamol tablet formulation.
    Esezobo S
    J Pharm Pharmacol; 1985 Mar; 37(3):193-5. PubMed ID: 2858567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories.
    Chicco D; Grabnar I; Skerjanec A; Vojnovic D; Maurich V; Realdon N; Ragazzi E; Belic A; Karba R; Mrhar A
    Int J Pharm; 1999 Nov; 189(2):147-60. PubMed ID: 10536243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
    Katori N; Aoyagi N; Terao T
    Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of paracetamol from amylodextrin tablets: in vitro and in vivo results.
    van der Veen J; Eissens AC; Lerk CF
    Pharm Res; 1994 Mar; 11(3):384-7. PubMed ID: 8008703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
    Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
    Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling.
    Abuzarur-Aloul R; Gjellan K; Sjölund M; Graffner C
    Drug Dev Ind Pharm; 1998 Apr; 24(4):371-83. PubMed ID: 9876598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.